Filling in the gaps in PARP inhibitor-induced synthetic lethality
暂无分享,去创建一个
[1] M. Wood,et al. Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells. , 2021, Molecular cell.
[2] J. Bartek,et al. Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps. , 2021, Molecular cell.
[3] Alberto Ciccia,et al. REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. , 2021, Molecular cell.
[4] J. Bartek,et al. Loss of Nuclear DNA Ligase III Reverts PARP Inhibitor Resistance in BRCA1/53BP1 Double-deficient Cells by Exposing ssDNA Gaps , 2021, bioRxiv.
[5] S. Ganesan,et al. Understanding and overcoming resistance to PARP inhibitors in cancer therapy , 2021, Nature Reviews Clinical Oncology.
[6] S. Cantor,et al. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency. , 2021, Molecular cell.
[7] S. Cantor,et al. Replication gaps underlie BRCA-deficiency and therapy response , 2019, bioRxiv.
[8] M. Lopes,et al. Rad51 protects nascent DNA from Mre11 dependent degradation and promotes continuous DNA synthesis , 2010, Nature Structural &Molecular Biology.
[9] M. Lopes,et al. Multiple mechanisms control chromosome integrity after replication fork uncoupling and restart at irreparable UV lesions. , 2006, Molecular cell.